Page last updated: 2024-08-22

1-phenyl-3,3-dimethyltriazene and aminolevulinic acid

1-phenyl-3,3-dimethyltriazene has been researched along with aminolevulinic acid in 2 studies

*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]

*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Buchner, A; Gederaas, OA; Pohla, H; Pongratz, T; Rühm, A; Shi, L; Sroka, R; Stepp, H; Wang, X; Zhang, L; Zimmermann, W1
Guo, H; Liu, Y; Sun, Y; Tu, C; Wu, H; Wu, Y; Xiao, B; Zhang, Y1

Other Studies

2 other study(ies) available for 1-phenyl-3,3-dimethyltriazene and aminolevulinic acid

ArticleYear
MOP-dependent enhancement of methadone on the effectiveness of ALA-PDT for A172 cells by upregulating phosphorylated JNK and BCL2.
    Photodiagnosis and photodynamic therapy, 2020, Volume: 30

    Topics: Aminolevulinic Acid; Apoptosis; Cell Line, Tumor; Humans; MAP Kinase Kinase 4; Methadone; Phosphorylation; Photochemotherapy; Photosensitizing Agents; Proto-Oncogene Proteins c-bcl-2; Receptors, Opioid, mu; Triazenes

2020
The assessment of psychology, quality of life in acne patients and evaluation of ALA-PDT for moderate to severe acne.
    Photodiagnosis and photodynamic therapy, 2021, Volume: 33

    Topics: Acne Vulgaris; Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Quality of Life; Treatment Outcome; Triazenes

2021